Ernexa Therapeutics (ERNAW) Tax Provisions (2010 - 2026)
Ernexa Therapeutics (ERNAW) reported Tax Provisions of -$40000.0 for Q1 2026, down 600.0% on a YoY basis from $8000.0 in Q1 2025, and down 185.71% quarter-over-quarter from -$14000.0 in Q4 2025.
Ernexa Therapeutics (ERNAW) Tax Provisions (2010 - 2026) Analysis & Trends
Ernexa Therapeutics has reported Tax Provisions for 17 years, with the latest figure at -$40000.0 in Q1 2026.
- For the quarter ending Q1 2026, Tax Provisions fell 600.0% year-over-year to -$40000.0; the trailing twelve-month figure through Mar 2026 stood at -$45000.0 (down 742.86% YoY), and the FY2025 full-year result was $3000.0, changed 0.0% from the prior year.
- Tax Provisions for Q1 2026 stood at -$40000.0, down from -$14000.0 in the prior quarter.
- The five-year high for Tax Provisions was $12000.0 in Q3 2024, with the low at -$40000.0 in Q1 2026.
- Historically, Tax Provisions has averaged -$2200.0 across 5 years, with a median of $3000.0 in 2024.
- Annual changes were most pronounced in 2024 — Tax Provisions jumped 250.0% — and 2026, when it tumbled 600.0%.
- Ernexa Therapeutics' Tax Provisions stood at -$1000.0 in 2022, then slumped by 300.0% to -$4000.0 in 2023, then slumped by 300.0% to -$16000.0 in 2024, then increased by 12.5% to -$14000.0 in 2025, then plunged by 185.71% to -$40000.0 in 2026.
- The last three Tax Provisions figures came in at -$40000.0 (Q1 2026), -$14000.0 (Q4 2025), and $6000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -11.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 216,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -859,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 221.50 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Ernexa Therapeutics | - | - | - | -40,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -40,000.00 |
| Dec 31, 2025 | -14,000.00 |
| Sep 30, 2025 | 6,000.00 |
| Jun 30, 2025 | 3,000.00 |
| Mar 31, 2025 | 8,000.00 |
| Dec 31, 2024 | -16,000.00 |
| Sep 30, 2024 | 12,000.00 |
| Jun 30, 2024 | 3,000.00 |
| Mar 31, 2024 | 4,000.00 |
| Dec 31, 2023 | -4,000.00 |
| Sep 30, 2023 | -8,000.00 |
| Jun 30, 2023 | 4,000.00 |
| Mar 31, 2023 | 5,000.00 |
| Dec 31, 2022 | -1,000.00 |
| Sep 30, 2022 | 5,000.00 |
| Dec 31, 2021 | 64,000.00 |
| Dec 31, 2020 | 23,000.00 |
| Sep 30, 2020 | -19,000.00 |
| Mar 31, 2020 | -19,000.00 |
| Dec 31, 2019 | -53,000.00 |